Jun 24, 2026 03:14AM
Jun 24, 2026 03:05AM
Jun 15, 2026 12:00PM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
Jun 9, 2026 04:30PM
Jun 9, 2026 04:30PM U.S. FDA Accepts Takeda's Application for Intravenous ENTYVIO® (vedolizumab) in Pediatric Ulcerative Colitis and Crohn's Disease
May 13, 2026 05:46AM
May 13, 2026 02:38AM
May 4, 2026 08:00AM
May 4, 2026 08:00AM
Mar 30, 2026 04:21AM
Mar 28, 2026 03:00PM
Mar 2, 2026 06:01AM FDA accepts rusfertide application with priority review for blood disorder
Mar 2, 2026 02:00AM
Feb 19, 2026 12:00PM
Feb 19, 2026 12:00PM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 29, 2026 01:37AM
Jan 22, 2026 07:45AM Takeda launches GAMMAGARD LIQUID ERC immunoglobulin therapy in US
Jan 22, 2026 07:45AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 18, 2025 03:00AM
Dec 18, 2025 03:00AM
Dec 8, 2025 02:54AM Protagonist and Takeda report 52-week rusfertide data in polycythemia vera
Dec 6, 2025 09:30AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Nov 3, 2025 08:33AM
Nov 3, 2025 07:00AM
Oct 30, 2025 03:04AM
Oct 27, 2025 08:35AM HyHub™ and HyHub™ Duo Devices Now Available in the U.S. to Simplify HYQVIA® Infusion Preparation
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 23, 2025 06:04PM
Sep 16, 2025 08:02AM
Sep 16, 2025 08:00AM
Sep 11, 2025 08:45AM
Sep 11, 2025 08:45AM Takeda Appoints Rhonda Pacheco President of the U.S. Business Unit
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:01AM
Jul 21, 2025 08:00AM Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration
Jul 14, 2025 05:55AM

1,165,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All